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Audiovestibular manifestations of the antiphospholipid
syndrome
TIM VYSE, LINDA M. LUXON*, MARK J. WALPORT
Abstract
We report on two patients who have high titres of antiphospholipid antibodies, both of whom had acute audiovestibular
failure. One of the patients had systemic lupus erythematosus. The other patient had primary antiphospholipid syndrome:
audiovestibular symptoms have not been reported in this condition. The occurrence of acute audiovestibular failure in the
primary antiphospholipid syndrome raises the question as to whether patients presenting with acute deafness or vestibular
disturbance should be screened for the presence of anticardiolipin antibodies.
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Introduction
Abnormalities of the audiovestibular system have not been docu-
mented extensively in patients with systemic lupus erythemato-
sus (SLE), although cranial nerve palsies are well described
(Johnson and Richardson, 1968; Feinglass et al., 1976). A sig-
nificant number of the neuropsychiatric features that occur in
SLE have been associated with the presence of circulating anti-
phospholipid antibodies (Harris et al., 1984); many of these
clinical features have also been documented in patients with the
primary antiphospholipid syndrome (Mackworth-Young et al.,
1989), who do not have sufficient clinical or serological features
to fulfil classification criteria for SLE. Antiphospholipid anti-
bodies are associated with a tendency to form intravascular
thromboses. This may represent the underlying pathological
process accounting for some of the neurological abnormalities
that occur in patients with SLE and/or the primary antiphos-
pholipid syndrome (Hart et al., 1984; Lechner and Pabinger-
Fashing, 1985). We report two cases of presumed thrombotic
damage to the audiovestibular system in patients with antiphos-
pholipid antibodies, an addition to the spectrum of vascular
thrombosis associated with the presence of these
auto-antibodies.
Case reports
Case 1
A 34-year-old female had a three-month history of malaise
and fever and two weeks of episodic dizziness and occasional
vertigo and nausea. There was a history of previous photo-
sensitivity but no history of joint pains. On examination she had
bilateral cervical lymphadenopathy and bilateral pleural effu-
sions; no neurological abnormality was found. Schirmer's test
was normal.
Investigations revealed a normocytic, normochromic ana-
emia, Hb 9.8 g/dl, total leucocyte count of 8.7 x 109/l, and
thrombocytopenia platelets 87 x 109/l. The ESR was elevated at
98 mm in the first hour. There was evidence of renal impairment
with a serum creatinine of 150 |imol/l, an albumin of 29 g/1, and
creatinine clearance of 43 mm/min. The 24 h urinary protein
was 1.0 g. Urine microscopy showed granular casts. Immu-
noglobulin values were: IgG 20.1 g/1; IgA 1.85 g/1; and igM
1.20 g/1. Serological investigations revealed antinuclear anti-
body (using Hep-2 cells as substrate) at a low titre of 1 : 80
(speckled); antibody to double-stranded DNA was 10 per cent
(normal < 30 per cent: Fair assay); antibodies to extractable
nuclear antigens, Ro and La, were detected by counter-immu-
noelectrophoresis; latex agglutination for rheumatoid factor was
negative; C3, C4 and CH50 were normal.
Coagulation studies showed normal prothrombin time and
activated partial thromboplastin time. No lupus anticoagulant
was detected by a dilution phospholipid method (Alving et al.,
1985). Circulating anticardiolipin antibodies (ACA) were found
by ELISA (Loizou etal, 1985), with an IgG value of 111 ELISA
units (normal < 9 units), and an IgM of < 0.2 ELISA units
(normal < 8 units). VDRL was negative. Lymph node biopsy
showed reactive changes only; bone marrow trephine revealed
normal trilineage precursors; renal biopsy showed a diffuse glo-
merulonephritis without crescents or evidence of significant
necrosis.
SLE was diagnosed and the patient was treated with 40 mg of
prednisolone. After one year's treatment she was well apart from
continuing episodes of visually-induced disorientation and sick-
ness together with vertigo particularly on sudden head move-
ments. Neuro-otological examination showed a total right canal
paresis, despite irrigation at 20°C for 1 min. There was no signifi-
cant electronystagmographic finding. Pure tone audiometry,
tympanometry, ipsilateral and contralateral stapedial reflex
thresholds and brain stem evoked responses were normal. A
magnetic resonance image (MRI) of the head was obtained
which showed scattered, but small high signal areas within the
deep white matter of the cerebrum and a small right-sided middle
cerebellar peduncle lesion.
Case 2
A 23-year-old primigravida presented as an emergency when
27 weeks pregnant with fulminant pre-eclampsia. Initially her
blood pressure was 170/110 mmHg; there was peripheral
oedema, and proteinuria ++ on Stix analysis, but no active sedi-
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ment on microscopy. She was restless and there was generalized
hyper-reflexia; no other neurological signs were found. Intra-
venous diazepam and hydralazine were administered. Her blood
pressure was readily controlled and she underwent an emer-
gency Caesarean section. A live infant of 750 g was delivered
but he had respiratory difficulties and died one week later. The
patient remained confused for the next five days requiring con-
tinuing antihypertensives and sedation. She developed thrombo-
cytopenia with a peripheral count of 28 x 109/l, Hb was 10.5 g/1
and WBC was 4.3 x 109/l; a bone marrow trephine showed evi-
dence of bone marrow necrosis. She was managed with regular
platelet transfusions until there was spontaneous marrow recov-
ery four weeks later. During this time there was no overt evi-
dence of haemorrhage.
As her mental state improved it became apparent, some three
days after presentation, that she was severely deaf and she com-
plained of tinnitus and loss of balance. Her external ocular move-
ments were normal but her gait was broad-based and unsteady.
Neither at this time nor previously did she have a history of
arthralgia, skin rashes, Raynaud's or alopecia; and there was no
antecedent history of migraine. Neuro-otological investigation
revealed a total loss of auditory acuity in the left ear and pro-
found loss in the right, but there was an island of hearing at
250 Hz and 500 Hz. Tympanometry revealed low-normal com-
pliance of the tympanic membranes, but absent stapedial
reflexes both ipsilaterally and contralaterally. The caloric
responses were absent bilaterally, despite irrigation at 20°C for 1
min.
Investigations at the time of presentation showed abnormal
blood coagulation: prothrombin time (PT) was 12 s (control
< 13 s); partial thromboplastin time (PTTK) 60 s (normal
< 41 s), the fibrin degradation products were not elevated.
When her audiovestibular symptoms developed they were
repeated: PT was 10 s; PTTK was 39 s; and there was a weakly-
positive lupus anticoagulant by phospholipid dilution; ACAs
were present: IgG was grossly elevated at 300 ELISA units
(normal < 9 ELISA units); and IgM 0.9 ELISA units (normal
< 8 ELISA units). In addition she had a false-positive biological
test for syphilis: VDRL positive, TPHA and FTA-ABS negative;
it is of note that when 12 weeks pregnant she was VDRL nega-
tive. Antinuclear antibodies, antibodies to extractable nuclear
antigen and rheumatoid factor were not detected. Immunoglobu-
lins were normal.
She was treated with 40 mg of prednisolone. Four weeks later
she developed a painful right leg, a femoral vein thrombosis was
confirmed by Doppler ultrasonography and she was anticoag-
ulated with warfarin. After five years follow-up there is no
improvement in her hearing, but there have been no clinically-
apparent thrombotic events and she remains anticoagulated. Her
ACA IgG titre remains very high (between 200 and 300 ELISA
units), other lupus serology remains negative.
Discussion
Circulating antibodies to anionic phospholipids are associated
with a clinical syndrome which comprises thrombosis, thrombo-
cytopenia, and recurrent foetal loss (Harris et al., 1985); they
may be detected directly, as ACA, by immuno-assay (Harris et
a!., 1983), or in a proportion of cases as a lupus anticoagulant
(LA) (Alving et al., 1985) or using the VDRL reagent. The
disease most frequently described in association with ACA is
SLE (Harris et al., 1986). It is not known what proportion of
patients with ACA and SLE disease have the primary antiphos-
pholipid syndrome (Mackworth-Young et al., 1989), but it has
been shown that some 50 per cent of those with LA do not have
an associated condition (Elias and Eldor, 1984). Very high titres
of ACA, as was found in the two cases presented, are associated
with a greater tendency to thrombosis (Harris et al., 1986).
A broad range of neurological features have been described in
association with ACA and/or LA with a demonstrable vascular
aetiology such as stroke, transient ischaemic attack, and multi-
infarct dementia (Elias and Eldor, 1984; Harris et al., 1984; Ash-
erson et al., 1987) and vaso-occlusive ocular disease (Asherson
et al., 1989). Migraine is also described which may be associated
with stroke (Harris et al., 1984). Chorea (Bouchez et al, 1985)
and epilepsy (Clauvel et al., 1986) are also reported. These clini-
cal associations encompass both the primary antiphospholipid
syndrome and SLE.
The cranial nerve palsies reported in patients with SLE most
commonly give rise to facial weakness (VII), extra-ocular
muscle paresis (III, IV, VI), or pupillary abnormalities (III);
these are not most often seen in conjunction with long tract signs
making the brain stem the site of the lesion (Johnson and
Richardson, 1968; Feinglass et al., 1976). Involvement of the
Vlllth nerve is rare. Examples in the literature are few. Those in
which the pathological basis has been demonstrated are: (i) a
patient with acute onset of bilateral deafness who then developed
coma with a divergent gaze and a fixed dilated right pupil who
died after four days. At postmortem she was shown to have had a
right intracerebral haemorrhage but also numerous micro-
infants within the brain stem (Johnson and Richardson, 1968);
and (ii) a patient with transient vertigo and diplopia who had a
small pontine haemorrhage (Cluxton et al., 1943).
Auditory and vestibular symptoms alone, unassociated with
other brain stem symptoms and signs, are unlikely to arise from
brain stem ischaemia (Barber and Dionne, 1971). However, it is
possible that a vascular lesion of the internal auditory artery is
responsible for the audiovestibular features reported. Animal
experiments have identified three labyrinthine syndromes con-
sequent upon occlusion of the internal auditory artery: cochlear
symptoms alone, vestibular loss or a combination of cochlear
and vestibular dysfunction (Kimura and Perlman, 1958). More-
over, labyrinthine artery occlusion with ischaemia of the periph-
eral labyrinth has been shown to give rise to dizziness and/or
hearing loss as shown in a temporal bone study (Gussen, 1976).
Auto-immune-related labyrinthine disease has been described
although the pathogenesis has not been clearly established. Both
cellular and humoral mechanisms have been implicated (Barna
and Hughes, 1988). A study of the C3H/lpr murine model of
lupus has shown that there is degeneration of the stria vascularis
(Trumer et al., 1989). A temporal bone study in three cases of
SLE revealed fibrosis and new bone formation in the internal ear
(Yoonetal, 1989).
The findings in Case 1 indicate normal cochlear, Vlllth nerve
and auditory brain stem function as judged by auditory inves-
tigations. The loss of caloric function could be attributed to
ischaemia of the vestibular labyrinth extrapolating from earlier
animal work, but a recent study (Francis et al., 1992) has shown
that rarely a canal paresis may be attributable to a brain stem
lesion at the level of the middle cerebellar peduncle. As MRI
scanning identified a lesion in this site, and there is no evidence
upon auditory investigation of peripheral labyrinthine pathol-
ogy, it would be reasonable to assume that a small thrombotic
brain stem event had given rise to the vestibular abnormalities in
Case 1. This would accord well with the brain stem being the
primary site of pathology documented in other cranial nerve
lesions.
Case 2 presents a more difficult diagnostic problem. The
absence of associated neurological signs makes brain stem path-
ology unlikely. Bilateral total loss of auditory and vestibular
function secondary to neurological pathology would require
widespread brain stem involvement. The proximity of auditory
and vestibular elements within the Vlllth cranial nerve and the
peripheral labyrinth would suggest one of these two anatomical
sites as the most likely explanation of total auditory and ves-
tibular failure. Although the occurrence of simultaneous bilat-
eral thrombotic events within the audiovestibular system would
be surprising, in this case several vascular risk factors were oper-
ating and so peripheral labyrinthine ischaemia is the most
reasonable explanation for the clinical findings. It is pertinent
that in another case of bilateral profound sensorineural hearing
loss, sudden deafness in one ear was followed three weeks later
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by profound deafness in the other ear, in a middle-aged woman
who was subsequently diagnosed as suffering from SLE (Cal-
derelli et al., 1984). The time course in this case is suggestive of
thrombotic events. In addition, bilateral sudden onset of
cochleovestibular failure in a young woman was recently
reported in a case of polyarteritis nodosa, although no infor-
mation as to the site of pathology was given (Row-Jones et al.,
1990).
ACAs are associated with occlusive vascular disease of the
nervous system. We have described two patients with very high
titres of these antibodies who suffered acute auditory and ves-
tibular failure. One of these patients also had SLE and ischaemic
brain stem events have been documented as the cause of cranial
nerve dysfunction in other cases of SLE. MRI scanning con-
firmed this pathological process in Case 1. The second patient
had ACA with no associated connective tissue disease. At the
onset of her deafness she was unwell with pre-eclampsia and
bone marrow necrosis, however, her blood pressure was control-
led and her platelet count maintained above 12x 209/l with no
obvious evidence of bleeding. Both are clearly independent vas-
cular risk factors in addition to the ACA. Her condition was
compatible with bilateral occlusive vascular disease. The second
case raises the possibility that instances of what might be thought
of as idiopathic auditory and/or vestibular failure could have a
definable vascular aetiology with underlying antiphospholipid
antibodies. Although some of the primary cases may give a
history of recurrent abortion or venous thrombosis this is not
invariable (Mackworth-Young et al., 1989) and hence the con-
dition is only diagnosed if LA, and ACA titres are measured.
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